Human Growth Hormone Risks Headlines
Little Boy With Prader-Willi Syndrome Starts Human Growth Hormone Therapy
Two year-old Junior Takehara of Gig Harbor is getting nightly HGH shots to treat a rare genetic condition that causes chronic hunger. Did you eat your dinner tonight? If not, your stomach's probably growling right about now. Imagine what that would feel like all of the time. That's what a Gig Harbor boy deals with every day.
Read more...
Is Meat and Milk From Clones Really Safe?
Is Meat and Milk From Clones Really Safe? It's just a matter of time before the US is eating clones, if it is not eating them now.
Read more...
The Conversation: Selling the Fountain of Youth
With baby boomers now reaching retirement age, more Americans are pursing the goal of looking and feeling young with measures far more drastic than the beauty creams and cosmetic procedures of the past. Author Arlene Weintraub's new book, "Selling the Fountain of Youth," tracks the explosion of the anti-aging business in the past two decades into an $88 billion industry. Fountain of Youth - Baby ...
Read more...
Delay of game? Owners, players preparing for labor battle after 2010
Chiefs veterans Brian Waters and Mike Vrabel know what it’s like at the negotiating table. It can get testy and nasty at times. As members of the NFL Players Association executive committee, they have debated, disputed, clashed and quarreled with NFL management and commissioner Roger Goodell.
Read more...
PROLOR Biotech Receives FDA Clearance For A Phase II Trial Of Its Long-Acting Human Growth Hormone In The U.S.
PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP...
Read more...
|